A polipoprotein E (apoE) is a 34-kD glycoprotein that circulates on plasma lipoproteins and serves as the ligand for their receptor-mediated clearance. 1 Although the majority of apoE is synthesized in the liver, 2 it is also expressed in a number of other tissues 3 by a wide variety of cell types, including tissue macrophages. 4 In addition, secretion of apoE from the artery wall appears to protect against the development of atherosclerosis. [5] [6] [7] Shimano et al 5 demonstrated that diet-induced atheroma formation could be inhibited by expression of apoE from the artery wall in transgenic mice. Bellosta et al 6 showed that the macrophagespecific expression of the human apoE3 transgene in apoE(Ϫ/Ϫ) mice results in smaller lesion area than that observed in control apoE(Ϫ/Ϫ) mice. Conversely, we have recently provided evidence that lack of macrophage-derived apoE promotes atherogenesis. 7 In this study, wild-type mice given apoE(Ϫ/Ϫ) marrow transplants (which resulted in a macrophage-specific apoE knockout) had a 10-fold greater lesion area than did control mice. Although these studies demonstrate a direct role for macrophage-derived apoE in atherogenesis, they do not indicate the possible mechanism by which macrophage apoE functions, nor do they delineate which stage of atherosclerotic development can be affected by apoE. The present study was designed to express constitutively low levels of apoE from arterial macrophages targeting 2 different stages of atherosclerosis. Our hypothesis was that macrophage apoE exerts a measurable effect only during the macrophage-rich stage of lesion growth and functions less in modulating the later stages of atherosclerosis, when lesions are characterized by smooth muscle cell proliferation, extracellular cholesterol clefts, and areas of necrosis and calcification. To this end, we used an approach of transduction of apoE(Ϫ/Ϫ) bone marrow with apoE-containing retroviral constructs, followed by transplantation of marrow into apoE(Ϫ/Ϫ) recipient mice. Here, we report that transplantation of apoE(Ϫ/Ϫ) mice with apoE-transduced bone marrow leads to the expression of apoE from arterial macrophages and that local low-level expression of apoE in the artery wall is capable of delaying foam cell formation but has no effect on later stages of atherosclerosis. These studies support the concept that macrophage apoE secretion is important in the early foam cell formation stage of atherogenesis and that apoE transgene expression from arterial macrophages may have therapeutic applications.
Methods

Cloning of Mouse and Human ApoE cDNA Into the pLXSN Retroviral Vector
Mouse apoE cDNA (exons 2 to 4) was amplified by reverse transcription-polymerase chain reaction. Random hexamers were used for the reverse-transcription portion of the reaction. Human apoE3 was amplified from an expression vector driven by the cytomegalovirus promoter. 8 Cycling conditions for both the mouse and human apoE consisted of 40 cycles of 97°C for 30 seconds, 62°C for 2 minutes, and 72°C for 2 minutes. The polymerase chain reaction products were used for ligation into the pLXSN retroviral vector and transfected into DH5␣ cells. Plasmid DNA from colonies was prepared and analyzed for the presence of the 1-kb apoE cDNA inserts. Plasmid DNA was prepared with the Plasmid Maxi kit obtained from Qiagen according to kit protocol. The sequence of the apoE cDNA inserts was confirmed by use of the ThermoSequenase kit (Amersham).
Preparation of Producer Cell Lines
The retroviral constructs were used to transfect the ecotropic packaging cell line Bosc-23, which has been shown to result in transient high-titer production of infectious virus. 9 The infectious supernatant from these cells was used to infect the amphotropic packaging cell line PA317. 10 The infectious medium from this cell line was then used to infect the ecotropic packaging cell line ⌿2 in a transinfection or "ping-pong-ping" method for creating high-titer producer cell lines. 11 The infected ⌿2 cells were selected for the integration of the provirus with the neomycin analogue G418 (Sigma) at 500 g/mL. Individual clones were isolated and analyzed for apoE expression and infectious titer. Individual producer cell clones were analyzed for viral titer as well as apoE secretion. Mouse apoE-expressing (pLMESN/⌿2), human apoE-expressing (pL-HESN/⌿2), and parental (pLXSN/⌿2) producer cells were selected for use in bone marrow transplant experiments. The producer cell lines used for bone marrow transplantation (BMT) studies were assayed for the presence of recombinant wild-type virus by the S ϩ L Ϫ assay 12, 13 and were found to be helper virus-free.
Bone Marrow Collection, Transduction, and Transplantation
Bone marrow was collected from apoE(Ϫ/Ϫ) donor mice by flushing femurs and tibias with RPMI 1640 with 2% FBS and 10 U/mL heparin (Sigma) added. Cells were washed, counted, and plated in suspension dishes, where proliferation was stimulated by preculturing with interleukin 3 (IL-3) and interleukin 6 (IL-6). IL-3 and IL-6 were produced by transfection of COS-7 cells (ATCC) with pCDmIL3 14 and pCD-mIL6. 14, 15 Bone marrow cells were precultured by plating 5ϫ10 6 cells in 10 mL of DMEM, 10% FBS, 3% IL-3, 3% IL-6 COS-7 medium for 48 hours. After preculture, bone marrow cells were collected and replated at the same density in the above medium with 6 g/mL hexadimethrine bromide (Sigma) onto dishes of 80% confluent producer cells for 48 hours. The suspended bone marrow cells were then collected and used to transplant lethally irradiated apoE(Ϫ/Ϫ) mice as previously described. 16 
Animal Procedures and Lipid Analyses
All mice used for these experiments were apoE(Ϫ/Ϫ) at the sixth backcross or higher into the C57BL/6 background and were originally purchased from Jackson Laboratories, Bar Harbor, Me. Mice were maintained in microisolator cages on a rodent chow diet (PMI No. 5010) containing 4.5% fat. All mice were given autoclaved water acidified to pH 2.6. One week before and 2 weeks after BMT, 100 mg/L neomycin (Sigma) and 10 mg/L polymyxin B sulfate (Sigma) were added to the acidified water. Blood samples were collected by retro-orbital venous plexus puncture with heparinized tubes, and serum was separated by centrifugation. Serum cholesterol and triglyceride levels were determined with clinical reagents on a microtiter plate assay, as previously described. 17 A 100-L aliquot of serum from mice was separated by Superose 6 chromatography on a Waters high-performance liquid chromatography system model 600 as described. 18 Animal care and experimental procedures were performed according to the regulations of Vanderbilt University's Animal Care Committee.
Western Blotting and Immunohistochemical Analysis for ApoE
Serum samples were tested for the presence of mouse or human apoE by Western blot analysis as described. 19 The primary antibodies used were polyclonal rabbit anti-mouse apoE (BioDesign International) and polyclonal goat anti-human apoE (BioDesign). Similar Western blot analyses were performed on fast protein liquid chromatography samples after concentration of pooled fractions by centrifugation with Microcon-10 columns (Amicon). Immunocytochemical analysis of tissue samples for macrophages and mouse apoE was performed essentially as described. 7 Briefly, 5-m sections were fixed in acetone and incubated with either a rat monoclonal antibody to macrophages, MOMA-2 (Accurate Chemicals), or a rabbit polyclonal antibody to mouse apoE (BioDesign International). Signal was detected with the ABC kit (Vector Laboratories) followed by incubation with the fast red TR/naphthol As-NX substrate (Sigma). Photomicroscopy was performed on a Zeiss Axiophot with Plan-FLUAR objectives.
Primary Macrophage Cultures
Peritoneal cells were collected 2 days after injection of thioglycollate as described, 20 counted, and plated into 12-well dishes at 1ϫ10 6 cells/well in DMEMϩ10% FBS. After 2 hours, nonadherent cells were removed. Wild-type, C57BL/6 mouse peritoneal leukocytes collected and plated in the same manner served as a positive control. Medium was collected from macrophages at 48-hour intervals and frozen in 1 mmol/L PMSF for Western blot analysis.
Lesion Area Quantification
Experiments were designed in 2 parts: (1) male 5-week-old apoE(Ϫ/Ϫ) mice killed at 13 weeks and (2) female 10-week-old apoE(Ϫ/Ϫ) mice killed at 26 weeks. Atherosclerosis studies in apoE(Ϫ/Ϫ) mice have not demonstrated any sex differences in extent of lesion formation. 21 Frozen sections 10 m thick were cut from the region of the proximal aorta starting from the end of the aortic sinus and continuing distally, according to the technique of Paigen et al. 22 Sections were stained with oil red O and counterstained with hematoxylin. Quantification of lesion area was performed on 15 sections per animal by digitizing morphometry and was reported in mean m 2 /section. Computer morphometry was performed with the KS300 software by Kontron Elektronik on a Compaq Presario 9240. Statistical analyses were performed with both Student's t test and the Mann-Whitney rank sum test comparing control and experimental lesion area in both experiments.
Results
Reconstitution of ApoE(؊/؊) Mice With Transduced Marrow
Mouse apoE and human apoE were detected in the serum of experimental mice as early as 3 weeks post-BMT and were expressed at levels Ϸ0.5% to 1% and 5% of normal, respectively ( Figure 1 ). Levels of apoE in serum were consistent between animals and over time. ApoE was expressed for as long as 5.5 months post-BMT. Serum cholesterol and triglycerides, measured pre-BMT and at 6 or 8 weeks post-BMT, showed no significant changes from baseline (Table) . To evaluate whether recipients of retrovirusinfected marrow developed immunity against the foreign antigen (apoE), we performed a Western blot assay of mouse plasma using the plasma of a retrovirus-infected mouse (pLMESN) as the primary antibody source. No apoE was detected even on undiluted normal mouse plasma when a 1:50 dilution of pLMESN plasma was used as antibody source, suggesting that no anti-apoE immunoglobulins were present in the plasma of retrovirus-infected mice (data not shown).
The distribution of serum lipoproteins in experimental and control mice was similar to that in nontransplant apoE(Ϫ/Ϫ) mice as determined by gel filtration chromatography (data not shown). Both mouse and human apoE were found to be associated with lipoproteins, with most of the apoE on the large VLDL and on IDL/LDL (Figure 2 ). ApoE was detected in HDL fractions on longer exposures.
Evidence of Stem Cell Transduction
The prolonged apoE expression in transplant mice suggests that pluripotent stem cells or early progenitor cells were transduced, because the progeny of late-stage progenitors probably persist in circulation for no more than 3 to 4 months. 23 To investigate whether stem cells had been transduced, a secondary transplantation was performed. Bone marrow was collected from 3 of the murine apoE-expressing mice 16 weeks post-BMT and transplanted into 6 lethally irradiated apoE(Ϫ/Ϫ) recipient mice. ApoE was detected in serum at 3 months post-BMT in these secondary transplant mice, providing further evidence for stem cell transduction in the original transplants (Figure 3) .
Analysis of ApoE Expression by Peritoneal and Arterial Macrophages
ApoE expression in the medium of BMT macrophages was 0.5% that of C57BL/6 macrophages ( Figure 4) . ApoE was also expressed from other tissues, such as the spleen and the artery wall. Immunocytochemistry analyses showed that apoE was secreted by arterial macrophages of pLMESN/⌿2 mice from the 5-to 13-week group ( Figure 5 ) as well as the 10-to 26-week group (data not shown). These apoEproducing macrophages were found throughout the plaques and at the valve cusps, but there was a high degree of variability in apoE expression between individual experimental mice. Of a total of 14 mice in the treated group of the "late Total serum cholesterol of retroviral BMT mice that received apoE(Ϫ/Ϫ) marrow cocultured with either pLMESN/⌿2, pLHESN/⌿2, or pLXSN/2 (control). Values are in mg/dL (meanϮSD). The number of animals in each group at each time point is indicated by n. There was no significant difference between post-BMT and baseline cholesterol or triglyceride values in any of the groups. study," 2 showed apoE in 60% to 80% of the arterial macrophages, 5 in 30% to 40%, and 6 in 10% to 20%, and 1 had undetectable apoE. This degree of variability was similar to that observed in the mice of the "early" group, in which significant effects on lesion growth were observed.
Serum Cholesterol Analysis in Mice After Bone Marrow Transplantation With Transduced Marrow
Quantification of Atherosclerosis
In mice that received transplants at 10 weeks of age and were killed at 26 weeks of age, there were no significant differences in the extent or distribution of lesions detected between the experimental (mouse apoE, nϭ23) and control groups (nϭ21) (186 282Ϯ97 333 versus 183 168Ϯ88 771 m 2 ϮSEM, respectively). In contrast, experimental mice given transplants of either murine (nϭ11) or human (nϭ15) apoE at 5 weeks of age and killed at 13 weeks of age had significantly smaller lesions than control mice (nϭ9) (4847Ϯ2410, 5294Ϯ2868, and 12 837Ϯ7166 m 2 ϮSEM, respectively) ( Figure 6 ). The differences between murine or human apoE-expressing mice and controls were significant at the level of PϽ0.003 and PϽ0.002, respectively (Student's t test and Mann-Whitney rank sum test). There was no difference between mice that expressed either murine or human apoE. By immunocytochemistry analysis, no major differences in plaque composition were detectable between treated and control groups in either study.
Discussion
In this study, we demonstrate that retroviral infection of bone marrow with an apoE-containing retrovirus leads to expression of the apoE transgene in apoE(Ϫ/Ϫ) mouse recipients of BMT, resulting in secretion of apoE by macrophages in the artery wall. ApoE was present in the serum of experimental mice for as long as 5.5 months after transplantation, at levels of Ϸ0.5% to 1% of normal, and was associated with lipoproteins. ApoE was expressed by both splenic and peritoneal macrophages, as well as by macrophages within the artery wall of transplant mice. Finally, both human and mouse apoEs were effective in reducing foam cell formation when expressed during early atherogenesis but had no effect during later stages of atherogenesis.
In the first experiment, mice received transplants at 5 weeks of age and were followed up until 13 weeks. When normal marrow is used to reconstitute apoE(Ϫ/Ϫ) mice, apoE is not detected in serum until 3 weeks post-BMT. 16 Therefore, mice in the present study expressed apoE only from 8 to 13 weeks of age (monocyte adhesion and foam cell formation stages of atherogenesis). Although plasma lipid levels were not affected by the intervention, mice that expressed either mouse or human apoE had significantly smaller lesion area (2-to 7-fold) than controls (PϽ0.003, mouse apoE versus controls, and PϽ0.002, human apoE versus controls). These data demonstrate that low-level apoE expression from arterial Immunoblot analysis of apoE secreted from cultured peritoneal macrophages. Peritoneal leukocytes were collected from experimental and control transplant mice from the early group at time of death. Macrophages were plated and media collected as described in Methods section. Media were concentrated in Microcon-10 concentration columns by Amicon. Lane 1 contains nonconditioned DMEM with 10% FBS, and lane 2 contains medium from cultured C57BL/6 macrophages at a dilution of 1:200, compared with medium used for remaining samples. Lanes 3 through 6 are samples from macrophages of murine apoE-expressing bone marrow transplant mice, and lanes 7 and 8 contain medium from macrophages of control mice. Dense band seen above apoE in lanes 2 through 8 is due to nonspecific binding of antibody with proteins from concentrated cell growth medium. macrophages is able to modulate early atherogenic events even when expressed for only a few weeks. The second group received transplants at 10 weeks and were allowed to progress until 26 weeks. The apoE in these mice was therefore expressed at the beginning and well into the intermediate lesion formation stage. In these mice, low levels of mouse apoE were expressed for a longer time than in the younger group but had no apparent effect on lesion formation. These data support the concept that apoE expression from macrophages in the artery wall is important in the early stages of atherogenesis but is not beneficial when delivered to more advanced lesions. The difference in atherosclerosis between studies cannot be ascribed to variations in apoE expression level or duration in transplant mice. Dot blot assays using all the samples of all time points from all mouse groups confirmed that in every instance, plasma apoE levels were Ն0.5% of normal (not shown). In addition, secondary transplants using the marrow from retrovirus-infected mice from the late experiment show that apoE was detectable in the plasma of apoE null recipients of marrow from primary transplant mice, proving that long-lived stem cells were transduced during the original procedure ( Figure 3 ). Although we cannot exclude the possibility that the lack of apoE effect on atherosclerosis in the mice of the late experiment was specific for the female sex, previous work from other investigators shows that progression and composition of arterial plaques in apoE null mice is not significantly different between sexes. 21, 24 Because no macrophage-specific promoter was used in this study, it is possible that other bone marrow-derived cell lines may have contributed to plasma apoE levels in reconstituted mice. The question of which cell type expressed apoE in the retrovirus-infected mice was indirectly addressed in a series of experiments comparing apoE levels in plasma and in macrophage-conditioned medium of either the retrovirusinfected apoE null mice (pLMESN) or apoE null mice that received 2 different dilutions (5% and 10%) of C57BL/6 marrow in apoE null marrow. Because the macrophage is the only apoE-producing cell line derived from normal unmanipulated bone marrow, we used the ratio between the densitometric readings of plasma and macrophage medium apoE in normal transplant mice as a comparative marker of the contribution of macrophages to plasma apoE in retrovirus-infected mice. The data (not shown) are compatible with the notion that Ϸ70% of apoE in the plasma of these mice is derived from macrophages, whereas only 30% derives from other leukocytes.
The beneficial effect of apoE in the artery wall may be a result of one of several mechanisms: (1) the promotion of cholesterol efflux from the cholesterol-loaded macrophage 25 ; (2) the facilitation of reverse cholesterol transport from the artery wall 26 ; (3) the induction of remnant uptake through apoE-dependent pathways (as explained by the secretioncapture hypothesis) 27 ; or (4) its local effects on inflammatory processes such as platelet aggregation, 28 leukocyte activation, 29, 30 or growth factor sequestration (see Reference 31 for review). It is interesting to note that the level of human apoE in serum was higher than that of mouse apoE (Figure 1 ), but still no reduction in serum cholesterol levels was observed.
Although human apoE3 binds to the murine LDL receptor with lower affinity than mouse apoE, it was nonetheless as effective as mouse apoE in reducing lesion area in transplant mice. These data suggest that the mechanism of action of macrophage apoE in the artery wall is not completely explained by its receptor-binding properties.
Gene therapy has been considered a promising alternative for treatment of cardiovascular diseases, such as restenosis and atherosclerosis. 32, 33 The majority of studies performed to date have focused on eliminating smooth muscle cell proliferation in vascular injury models of restenosis. Several different approaches have been taken using adenoviral vectors to deliver many different categories of genes, including oligonucleotides against proto-oncogenes, 34 suicide genes, 35 and genes affecting cellular proliferation. 36 Although these studies have clearly demonstrated the potential for reducing smooth muscle cell proliferation after angioplasty procedures, they do not address the question of whether gene therapy for atherosclerosis might be possible. Endothelial cells, smooth muscle cells, and macrophages all contribute to atherogenesis and are potential target cells for gene therapy approaches. Because monocytes/macrophages are derived from bone marrow progenitors, can migrate into the vessel wall, and are involved in the very early events in atherogenesis, they are attractive targets for cell-mediated gene therapy of atherosclerosis.
This study clearly demonstrates that macrophage-derived apoE has a significant impact on foam cell formation but does not play a role in the later stages of atherogenesis, in which macrophages are no longer the principal cell type involved in the lesion formation. In addition, this study demonstrates the feasibility and efficacy of transduction of bone marrow followed by transplantation as a way to express transgenes from macrophages in the artery wall with potent effects on atherogenesis. ApoE represents only one of the many potential genes with therapeutic effects on atherosclerosis. Other genes related to lipoprotein metabolism, fibrinolysis, thrombosis, cell proliferation, and oxidation have a potential application for gene therapy of atherosclerosis if expressed from macrophages in the artery wall.
